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Abstract
Polycomb repression in mouse embryonic stem cells (ESCs) is
tightly associated with promoter co-occupancy of RNA polymerase
II (RNAPII) which is thought to prime genes for activation during
early development. However, it is unknown whether RNAPII pois-
ing is a general feature of Polycomb repression, or is lost during
differentiation. Here, we map the genome-wide occupancy of
RNAPII and Polycomb from pluripotent ESCs to non-dividing
functional dopaminergic neurons. We find that poised RNAPII
complexes are ubiquitously present at Polycomb-repressed genes
at all stages of neuronal differentiation. We observe both loss and
acquisition of RNAPII and Polycomb at specific groups of genes
reflecting their silencing or activation. Strikingly, RNAPII remains
poised at transcription factor genes which are silenced in neurons
through Polycomb repression, and have major roles in specifying
other, non-neuronal lineages. We conclude that RNAPII poising is
intrinsically associated with Polycomb repression throughout dif-
ferentiation. Our work suggests that the tight interplay between
RNAPII poising and Polycomb repression not only instructs
promoter state transitions, but also may enable promoter plastic-
ity in differentiated cells.
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Introduction
Embryonic differentiation starts from a totipotent cell and culmi-
nates with the production of highly specialized cells. In ESCs,
many genes important for early development are repressed in a
state that is poised for subsequent activation (Azuara et al, 2006;
Bernstein et al, 2006; Stock et al, 2007; Brookes et al, 2012).
These genes are mostly GC-rich (Deaton & Bird, 2011), and their
silencing in pluripotent cells is mediated by Polycomb repressive
complexes (PRCs). Genes with more specialized cell type-specific
functions are neither active nor Polycomb repressed in ESCs, have
AT-rich promoter sequences, and their activation is associated
with specific transcription factors (Sandelin et al, 2007; Brookes
et al, 2012).
Polycomb repressive complex proteins have major roles in
modulating gene expression during differentiation and in disease
(Prezioso & Orlando, 2011; Richly et al, 2011). They assemble in
two major complexes, PRC1 and PRC2, which catalyze H2AK119
monoubiquitination and H3K27 methylation, respectively (Simon &
Kingston, 2013). Both PRC-mediated histone marks are important
for chromatin repression, and synergize in a tight feedback loop to
recruit each other’s modifying enzymes (Blackledge et al, 2015).
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Although imaging studies suggest that PRC-repressed chromatin has
a compact conformation (Francis et al, 2004; Eskeland et al, 2010;
Boettiger et al, 2016), molecular and cell biology approaches show
that PRC repression in ESCs coincides with the occupancy of poised
RNAPII complexes and active histone marks in the vast majority of
PRC-repressed promoters (Azuara et al, 2006; Bernstein et al, 2006;
Stock et al, 2007; Brookes et al, 2012; Tee et al, 2014; Kinkley et al,
2016; Weiner et al, 2016). The co-occurrence of RNAPII and PRC
enzymatic activities, RING1B and EZH2, on chromatin has been
confirmed in ESCs by sequential ChIP (Brookes et al, 2012) and is
mirrored by the simultaneous presence of H3K4me3 and H3K27me3
marks, called chromatin bivalency (Azuara et al, 2006; Bernstein
et al, 2006; Voigt et al, 2012; Kinkley et al, 2016; Sen et al, 2016;
Weiner et al, 2016).
RNAPII function is regulated through complex post-transla-
tional modifications at the C-terminal domain (CTD) of its largest
subunit, RPB1, which coordinate the co-transcriptional recruit-
ment of chromatin modifiers and RNA processing machinery to
chromatin, leading to productive transcription events and mRNA
expression (Brookes & Pombo, 2009; Zaborowska et al, 2016). In
mammals, the CTD comprises 52 repeats of the heptapeptide
sequence N-Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7-C. At active
genes, RNAPII is phosphorylated on Ser5 (S5p) to mark transcrip-
tion initiation, on Ser7 (S7p) during the transition to productive
transcription, and on Ser2 (S2p) during elongation. S5p and S7p
are mediated by CDK7, while S2p is mediated by CDK9. RNAPII
also exists in a paused state of activation characterized by short
transcription events at promoter regions, followed by promoter-
proximal termination and re-initiation events (Adelman & Lis,
2012). RNAPII pausing is identified at genes that produce mRNA
at lower levels and is often measured as the amount of RNAPII
at gene promoters relative to its occupancy throughout coding
regions. Paused states of RNAPII are therefore a feature of genes
that are active to a lower extent, are characterized by the pres-
ence of S5p and S7p at gene promoters, low abundance of S2p
throughout the coding regions, and they are recognized by
8WG16, an antibody which has a preference for unphosphory-
lated Ser2 residues. The paused RNAPII complex is also charac-
terized by methylation and acetylation of the non-canonical Lys7
residues at the CTD (Schro¨der et al, 2013; Dias et al, 2015; Voss
et al, 2015).
The RNAPII complex that primes PRC-repressed genes in mouse
ESCs has a unique configuration of post-translational modifications
of the CTD, which is different from the paused RNAPII, and was
originally referred to as poised RNAPII (Stock et al, 2007; Brookes &
Pombo, 2009). The poised RNAPII is characterized by exclusive
phosphorylation of S5p in the absence of S7p, S2p, K7me1/2, K7ac,
or recognition by 8WG16 (Brookes et al, 2012; Dias et al, 2015).
Poised RNAPII-S5p, in the absence of 8WG16, has not been
described in Drosophila (Gaertner et al, 2012), consistent with lack
of chromatin bivalency (Vastenhouw & Schier, 2012; Voigt et al,
2013). Importantly, Ser5 phosphorylation of poised RNAPII
complexes at Polycomb-repressed genes in ESCs is mediated by dif-
ferent kinases, ERK1/2 (Tee et al, 2014; Ma et al, 2016), instead of
CDK7 which phosphorylates both S5p and S7p at active genes,
irrespectively of pausing ratio (Akhtar et al, 2009; Glover-Cutter
et al, 2009). Loss of ERK1/2 activity in ESCs results in the loss
of poised RNAPII-S5p and decreased occupancy of PRC2 at
Polycomb-repressed developmental genes (Tee et al, 2014), suggest-
ing a tight functional link between the presence of poised RNAPII-
S5p at Polycomb-target genes and the recruitment of Polycomb.
While histone bivalency has been studied to some extent during
mammalian cell differentiation and found present at smaller propor-
tion of genes (Mohn et al, 2008; Lien et al, 2011; Wamstad et al,
2012; Xie et al, 2013), it remains unexplored whether the co-occu-
pancy of poised RNAPII-S5p at PRC targets is a property of ESCs or
extends beyond pluripotency. The poised RNAPII-S5p state was
observed at Polycomb-repressed genes in ESCs grown in the presence
of serum and leukemia inhibitor factor (LIF; Stock et al, 2007;
Brookes et al, 2012; Tee et al, 2014; Ma et al, 2016). Other studies
grow ESCs in 2i conditions to simulate a more naı¨ve pluripotent state,
through inhibition of GSK3 and MEK signaling, which in turn inhibits
ERK signaling. In these conditions, the occupancy of poised RNAPII
complexes is reduced at Polycomb-target genes (Marks et al, 2012;
Williams et al, 2015), consistent with the effects of ERK1-2 inhibition
(Tee et al, 2014). Interestingly, the decreased occupancy of poised
RNAPII-S5p at PRC-repressed genes in 2i conditions is accompanied
by reduced occupancy of PRC2 catalytic subunit EZH2 and
H3K27me3 modification, suggesting a tight interplay between the
presence of poised RNAPII-S5p and Polycomb occupancy at Poly-
comb-repressed genes in ESCs, which is interfered upon in 2i condi-
tions. Interestingly, prolonged 2i treatment was shown to impair ESC
developmental potential and cause widespread loss of DNA methyla-
tion (Choi et al, 2017; Yagi et al, 2017), leading to renewed interest in
understanding the regulation of developmental genes, and in particu-
lar whether poised RNAPII complexes are a more general feature of
Polycomb repression mechanisms in the early and late stages of dif-
ferentiation. Recent studies of DNA methylation in differentiated
tissues show that many silent developmental regulator genes remain
hypomethylated in wide genomic regions (also called DNA methyla-
tion valleys; or DMVs) in differentiated tissues (Xie et al, 2013), rais-
ing the question of whether poised RNAPII complexes might prime
developmental regulator genes in cell lineages irrespectively of future
activation. In this scenario, Polycomb repression may represent the
universal mode of repression of this group of CpG-rich genes that
recruit poised RNAPII-S5p and which are not targeted by DNAmethy-
lation. Silencing of developmental regulator genes through Polycomb
repression mechanisms in fully differentiated cells, especially in the
presence of poised RNAPII complexes, may nevertheless have roles
in the remodeling of cell function, for example in response to specific
stimuli such as tissue injury, or in disease such as in cancers associ-
ated with Polycomb dysfunction.
To investigate RNAPII poising at Polycomb-repressed genes,
from pluripotency to terminal differentiation, we mapped
H3K27me3 (a marker of Polycomb repression), RNAPII-S5p (present
at both active and poised RNAPII complexes), and RNAPII-S7p (a
marker of productive gene expression) and produced matched
mRNA-seq datasets in ESCs and in four stages of differentiation of
functionally mature dopaminergic neurons. We show compelling
evidence that the presence of poised RNAPII at H3K27me3-marked
chromatin is not a specific feature of ESCs, but a general property
common to differentiating and post-mitotic cells. We also observe
de novo Polycomb repression during neuronal cell commitment and
neuronal maturation that promotes waves of transient downregula-
tion of gene expression. We discover a group of genes that maintain
poised RNAPII-S5p and Polycomb silencing throughout neuronal
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differentiation, and which are developmental transcription factors
important for cell specification toward non-neuronal lineages.
Although these genes are unlikely to be subsequently reactivated in
the neuronal lineage, their silencing in neuronal precursors and
mature neurons is sensitive to Polycomb inhibition or knockout. We
also show that the presence of poised RNAPII-S5p at specific subsets
of Polycomb-repressed genes in terminally differentiated neurons
coincides with their wide hypomethylation in mouse brain. Our
study reveals the interplay between RNAPII poising and Polycomb
repression in the control of regulatory networks and cell plasticity
throughout cell differentiation.
Results
Capturing distinct stages of differentiation from ESCs to
dopaminergic neurons
To study the dynamic changes in Polycomb and RNAPII occupancy
at gene promoters during differentiation, we optimized neuronal dif-
ferentiation protocols to obtain large quantities of pure cell popula-
tions required for mapping chromatin-associated histone marks and
RNAPII at five states of neuronal differentiation that leads to the
production of functional dopaminergic neurons (ESC, days 1, 3, 16,
and 30; Fig 1A). To capture the early exit from pluripotency, we
adopted an approach that starts from mouse ESCs grown in serum-
free and 2i-free conditions and which within 3 days achieves
synchronous exit from pluripotency toward the production of
neuronal progenitors (Abranches et al, 2009; Fig EV1A, top row).
To obtain terminally differentiated dopaminergic neurons, we used
an approach that commits ESCs to a midbrain neuron phenotype
(Jaeger et al, 2011; Fig EV1A, bottom row).
The expression of pluripotency markers Nanog and Oct4
decreases dramatically at days 1 and 3 of differentiation, respec-
tively (Fig 1B). The early differentiation marker Fgf5 is transiently
expressed in days 1–3, whereas neuronal markers Blbp, Hes5, and
Mash1/Ascl1 are increasingly expressed from day 2 (Figs 1B and
EV1B). The expression of Sox2, which encodes for a transcription
factor expressed in ESCs and by most central nervous system
progenitors (Graham et al, 2003), is detected from ESC to day 4, as
expected (Fig EV1B; Abranches et al, 2009). After sixteen days, we
obtained neurons that no longer express OCT4 protein, are positive
for the neuronal marker TUBB3 (detected by Tuj1 antibody), and no
longer divide, as assessed by lack of BrdU incorporation into newly
replicated DNA (Fig 1C).
To confirm the dopaminergic phenotype, we performed
immunofluorescence for tyrosine hydroxylase (TH), the rate-limiting
enzyme in dopamine synthesis (Fig 1D). The neuronal populations
obtained expressed TH from day 16, reaching close to ubiquitous
expression at day 30 (Fig 1D). Moreover, 70% of cells co-express
LMX1A and FOXA2 at day 16 (Fig EV1C), two markers specific to the
dopaminergic ventral midbrain, confirming that the neuronal popula-
tions produced are highly enriched for the dopaminergic lineage
(Hegarty et al, 2013). Taken together, these results indicate that day
16 neurons represent an immature stage of differentiation committed
to the ventral midbrain lineage, which further mature until day 30.
To characterize the changes in gene expression that accompany
neuronal differentiation, we produced mRNA-seq datasets for ESCs,
day 1, day 3, day 16, and day 30. We identified 4656 genes whose
expression levels peaked at one specific time point (Fig 1E). Genes
peaking in ESCs are enriched in Gene Ontology (GO) terms typical of
pluripotency, such as “stem cell maintenance”, “regulation of gene
silencing”, and “sugar utilization”, and include Nanog, Tet1, and
Hk2. Genes with highest expression on day 1 have roles in the exit
from pluripotency, such as Wt1, Foxd3, and Dnmt3b, and are
enriched in GO terms “cell morphogenesis”, “pattern specification
process”, and “gene silencing”. On day 3, the expression of Fgf8, Gli3
and HoxA1 peaked, reflecting an early stage of neuronal commit-
ment, highlighted by enrichment in GO terms such as “cellular devel-
opmental process”, “multicellular organismal process”, and
“neuronal nucleus development”. Day 16 coincided with highest
expression of genes associated with GO terms such as “nervous
system development”, “axon guidance”, and “neuron migration” (in-
cluding Nova1, Sema3f, Ascl1, Neurog2), and day 30 with genes
important for dopaminergic synaptic transmission, for the “G-protein
coupled receptor protein signaling pathway” and “response to alka-
loid” (such as Lpar3, Th, Park2, Chrnb4). The complete list of
enriched GO terms is presented in Dataset EV1. These expression
profiles show that each time point captures a specific stage of
neuronal development, and suggest that days 16 and 30 reflect early
and late stages, respectively, of maturation of dopaminergic neurons.
To further confirm the quality of our samples, we also explored
the expression profiles of specific single genes (Fig EV2). In addition
to confirming the expression of the differentiation markers studied
by quantitative PCR and immunofluorescence (Fig EV2A), we also
found that the proneural gene Ngn2 (expressed in immature, but
not in mature, dopaminergic neurons) peaks at day 16 and drops by
day 30, while Nurr1 (required for maintenance of dopaminergic
neurons) is upregulated at day 16 but remains expressed at day 30
(Fig EV2B; Ang, 2006). Other markers of dopaminergic neurons,
▸Figure 1. Model of differentiation from pluripotent stem cells to terminal dopaminergic neurons.A Schematic representation of the differentiation system used and the temporal expression dynamics of differentiation stage markers.
B RNA levels of differentiation stage markers were measured by qRT–PCR. Relative levels are normalized to Actb internal control, and values are plotted relative to the
highest expressed time point. Mean and standard deviation (SD) are from three biological replicates.
C Indirect immunofluorescence confirms expression of stage-specific markers at the single cell level. OCT4 is a marker of pluripotent ESCs. Tuj1 is an antibody that
detects neuronal marker TUBB3 at day 16 and day 30 neurons. The cycling activity of ESCs, day 16, and day 30 neurons was assessed by BrdU incorporation (24 h)
into replicating BrDNA. Nuclei are counterstained with DAPI. Scale bar, 100 lm.
D Tyrosine hydroxylase (TH; in red) is a marker of dopaminergic neurons. It is not expressed in ESCs and detected weakly in day 16 and broadly in day 30 neurons.
Nuclei are counterstained with DAPI. Scale bar, 100 lm.
E Gene expression dynamics across the differentiation time line for genes whose expression peaks in a single time point (z-score > 1.75; from mRNA-seq).
Representative enriched GO terms were calculated using as background all genes expressed (> 1 TPM) in at least one time point. n, number of genes per group.
Permute P-value (GO-Elite) is shown.
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such as Pitx3, Aadc, Vmat, and Dat, are most highly expressed at
day 30 (Fig EV2B).
Electrophysiological measurements demonstrate distinct stages
of neuronal maturation on days 16 and 30 of differentiation
To directly investigate the state of maturation of neurons upon
prolonged culture, we measured their action potential activity and
synaptic connectivity by conducting targeted whole-cell electrophysi-
ological recordings (Fig 2A) at four different time points (days 14–
16, 20–25, 26–30, and > 30). We find that days 14–16 neurons are
largely silent, whereas at days > 30 they exhibit robust spontaneous
action potential activity (Figs 2B and EV3A), similar to the activity of
midbrain dopaminergic neurons from ex vivo slice preparations and
in vivo (Marinelli & McCutcheon, 2014). During maturation, neurons
also exhibit a hyperpolarization-activated inward (Ih) current
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Figure 2. Whole-cell electrophysiological recordings from in vitro differentiated dopaminergic neurons show maturation of action potential firing and
synaptic activity.
A Differential Interference Contrast (DIC) and GFP images showing a glass micropipette recording from a Pitx3-GFP+ cell and examples of action potential (AP)
measurements. Scale bars, 35 lm. Immature neurons were generally silent or fired only a single AP; they progressively started firing multiple APs in response to a
depolarizing current pulse, evoked spontaneous APs generated in response to a constant depolarizing current injection, or spontaneous pacemaker-like APs when
they were fully mature.
B Graph shows progressive functional neuronal maturation toward spontaneous AP firing from days 14–16 to day 30 based on the % of their AP firing categories
(n = 21, 25, 10, 30; Spontaneous firing; chi-squared test for trend = 20.58, P-value < 0.0001).
C Two traces from different cells illustrating the presence (black, arrow) or absence (gray) of a hyperpolarization-activated inward current (Ih), evoked by a
hyperpolarizing voltage pulse of 120 mV. Graph shows mean and standard error of the mean (SEM). Ih amplitude progressively increases across differentiation days
(n = 22, 10, 12, 20; ANOVA = 2.565, P-value = 0.0483).
D Example trace of spontaneous excitatory post-synaptic currents (sEPSCs) recorded at 70 mV and application of 1 lM tetrodotoxin (TTX), which revealed miniature
EPSCs (mEPSCs).
E Spontaneous synaptic activity emerged at days 20–25. Graph shows percentage of neurons with spontaneous synaptic activity across differentiation days (n = 10, 19,
8, 5; chi-squared test for trend = 20.76, P-value < 0.0001). Frequency, but not amplitude of mEPSCs, continues to increase once synaptic activity has emerged (n = 7,
7, 10; Frequency ANOVA = 6.555, P-value = 0.0377; Amplitude ANOVA = 0.04457, P-value = 0.978). Graph shows SEM.
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(Fig 2C), an electrophysiological feature commonly used to identify
dopaminergic neurons (Ungless & Grace, 2012). Strikingly, after
prolonged culture many cells exhibit burst-like events (Fig EV3B and
C), often seen in vivo in midbrain dopaminergic neurons (Grace &
Bunney, 1984), which are thought to be driven in part by synaptic
inputs (Paladini & Roeper, 2014). We also observed maturation of
functional synaptic connectivity. Spontaneous synaptic events were
rare at days 14–16, but were present in most neurons from days 20–
25 onwards (Fig 2D and E). Further experiments in the presence of
TTX (which blocked action potential activity; Fig EV3D) revealed
the presence of glutamatergic AMPA receptor-mediated miniature
excitatory post-synaptic currents (mEPSCs; Fig EV3E) and GABAA
receptor-mediated miniature inhibitory post-synaptic currents
(mIPSCs; Fig EV3F), similar to those seen in ex vivo dopaminergic
neurons. Consistent with this, we also observed a small number of
GABAergic and glutamatergic neurons in our cultures (Fig EV3G), as
seen in the ventral tegmental area (VTA) of the midbrain in vivo, and
expression of GABAergic and glutamatergic neuronal markers
(Fig EV3H). Further evidence in support of the quality of our
neuronal samples was the absence of glutamatergic autapses
(Fig EV3I), which are seen in cultured ex vivo dissociated neurons,
but not in ex vivo brain slices (Sulzer et al, 1998).
We conclude that the neuronal differentiation approach estab-
lished here yields functional neurons that undergo progressive
maturation, as shown by their action potential activity and synaptic
connectivity. Taken together, gene expression and electrophysiologi-
cal analyses confirm that the five time points used here represent
distinct stages of neuronal fate commitment and maturation.
Polycomb repression dynamics during terminal differentiation of
dopaminergic neurons
To identify the genes regulated by Polycomb during neuronal speci-
fication, we mapped the genome-wide occupancy of H3K27me3, the
PRC2-mediated histone modification. In ESCs grown in serum-free
conditions, 4,107 genes are marked by H3K27me3 (Fig 3A), most of
which (78–86%) were also found targeted by PRC in ESCs in serum-
containing media (Lienert et al, 2011; Young et al, 2011; Brookes
et al, 2012), demonstrating the important roles of Polycomb repres-
sion mechanisms in ESCs independent from the use of serum.
Upon early exit from the pluripotent state, the number of
H3K27me3+ genes increases to ~4,600 in days 1 and 3, before
decreasing to ~2,200 genes in days 16 and 30 (Fig 3A). The abun-
dance of PRC-marked promoters in dopaminergic neurons suggests
an important role of Polycomb repression in differentiated cells,
which is consistent with previous reports in other specialized
cell types: pyramidal glutamatergic neurons (2,178 genes; Mohn
et al, 2008), striatal GABAergic neurons (2,057 genes; von
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A Numbers of PRC+ promoters from ESC to day 30. In terminally differentiated neurons, 2,178 genes are marked by H3K27me3.
B Dynamic changes in H3K27me3 presence at gene promoters. Vertical lines represent each of the promoters marked by H3K27me3+ in at least one time point.
Throughout differentiation, 1,408 genes are marked by H3K27me3 (PRC Maintained), 2,699 lose H3K27me3 (PRC Lost), and 1,565 gain H3K27me3 (PRC Acquired). Color
represents number of reads in transcription start site (TSS) window, scaled for visualization.
C Examples of enriched GO terms and gene examples among the groups of genes classified as PRC Maintained, Lost, and Acquired, using as background all genes.
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Schimmelmann et al, 2016), functional endocrine cells (1,273 genes;
Xie et al, 2013), and in E12.5 heart ventricle apex (1,052 genes; He
et al, 2012).
To study the dynamics of Polycomb repression across the dif-
ferent stages of differentiation, we grouped promoters according to
H3K27me3 presence or absence (Fig 3B). H3K27me3 marks a total
of 5,672 genes in at least one time point (Dataset EV2). Over half of
the H3K27me3+ genes in ESCs lose H3K27me3 between days 1 and
30 (“PRC lost” genes), while 1,408 genes remain H3K27me3+
throughout the differentiation timeline (“PRC maintained”; Fig 3C).
Genes that lose H3K27me3 include Fos, Zic1, Ncam1, and Wnt5a,
and are enriched in GO terms such as “nervous system develop-
ment”, “regulation of signaling”, and “cell adhesion”, consistent
with their activation upon acquisition of the neuronal phenotype.
Genes associated with PRC in all time points include developmental
transcription factors such as Nkx2-5, Pax6, and Gata4, and are
enriched in functions such as “anatomical structural development”,
“pattern specification process”, “regulation of cell differentiation”,
and “DNA dependent transcription”. De novo acquisition of
H3K27me3 is detected throughout differentiation (“PRC acquired”
genes), with a transient appearance of H3K27me3 at 931 genes
between days 1 and 3, and at 351 genes in post-mitotic neurons
(Fig 3C). These genes are enriched in GO terms such as “regulation
of cell proliferation” and include important signaling regulators as
Nodal, Notch1, and Fzd5. Our results show that genes targeted by
PRC during neuronal differentiation undergo dynamic changes at
appropriate stages of differentiation.
Poised RNAPII-S5p is present at H3K27me3+ promoters
throughout differentiation
To investigate whether poised RNAPII-S5p is lost from Polycomb-
repressed promoters upon exit from pluripotency, or associated with
Polycomb throughout terminal differentiation, we produced ChIP-
seq datasets for RNAPII-S5p and RNAPII-S7p in ESCs and at days 1,
3, 16, and 30 (Fig 4A). Inspection of single-gene profiles revealed
different promoter states and dynamic changes (Fig 4B). For exam-
ple, the housekeeping gene Eif2b2 is always expressed at the mRNA
level and occupied by RNAPII-S5p and RNAPII-S7p, whereas testis-
specific Brs3 is always inactive and lacks H3K27me3 and RNAPII-
S5p and RNAPII-S7p throughout our differentiation timeline. In
contrast, Adcy5, a gene implicated in axonal elongation and in
addiction (del Puerto et al, 2012; Procopio et al, 2013), is marked
by RNAPII-S5p and H3K27me3 in ESCs and becomes Active from
day 16, acquiring S7p, losing H3K27me3, and maintaining S5p.
Pkp1, which has roles in epidermal morphogenesis (South et al,
2003), is always marked by H3K27me3, but associated with poised
RNAPII-S5p only in ESCs and in early differentiation. Notably, Pitx1,
a transcription factor with roles in limb morphogenesis (Infante
et al, 2013), is marked by RNAPII-S5p and H3K27me3 at all five
time points, without S7p or mRNA expression. Examples of de novo
PRC repression include Ajuba, a gene implicated in cell-cycle
progression (Hirota et al, 2003) which is downregulated during dif-
ferentiation while acquiring H3K27me3, and retaining S5p, S7p, and
low levels of mRNA expression. Genes marked with H3K27me3,
RNAPII-S5p, and RNAPII-S7p in bulk ChIP assays have been previ-
ously described in ESCs and shown to correspond to promoter
fluctuations between active and PRC-repressed states in different
cells or alleles (Brookes et al, 2012; Kar et al, 2017).
For an unbiased exploration of the transitions between states of
Polycomb repression and productive transcription across differentia-
tion, we identified the promoters that are associated with RNAPII or
Polycomb in each time point. RNAPII-S5p marks both active and
PRC-repressed promoters, RNAPII-S7p marks only at active promot-
ers, and H3K27me3 marks PRC-repressed promoters. As previously
reported, most promoters marked by H3K27me3 in ESCs are also
bound by RNAPII-S5p (81%; Fig 4C; see also Brookes et al, 2012).
Importantly, we find that many promoters are positively marked by
RNAPII-S5p and H3K27me3 throughout differentiation, showing
that RNAPII poising at PRC-marked promoters is a general property
of Polycomb repression and not only specific to ESCs. During termi-
nal differentiation, PRC/S5p genes become increasingly marked by
RNAPII-S7p (Fig 4D) and expressed at the mRNA level (Fig 4E),
suggesting a role for PRC repression not limited to strict gene silenc-
ing, but also in modulating gene expression levels, as seen previ-
ously in ESCs (Brookes et al, 2012; Kar et al, 2017).
Genome-wide transitions in Polycomb repression states
To understand the dynamic transitions in promoter states through-
out differentiation, we classified genes according to the presence of
RNAPII-S5p, RNAPII-S7p, and H3K27me3, in each time point
(Fig 5A). PRC-positive promoters were classified as “PRC Only”
(H3K27me3+S5pS7p), as “PRC/S5p” (H3K27me3+S5p+ S7p),
and as “PRC/Active” (H3K27me3+S5p+S7p+). PRC-negative promoters
were classified as “Active” (H3K27me3S5p+S7p+), or as “Inactive”
(H3K27me3S5pS7p). The other three combinations of promoter
marks (S7p Only, S5p Only, and PRC/S7p) were uncommon and not
explored further in the present study. The numbers of genes in each
state are summarized in Fig EV4A; gene promoter states are listed
in Dataset EV2. We found that the decrease in the number of
promoters marked by PRC is accompanied by an increase in Active
▸Figure 4. RNAPII-S5p overlaps with Polycomb at all stages of differentiation.A Schematic summarizing the strategy used to define promoter states through differentiation based on the interplay between PRC and RNAPII.
B Examples of single-gene ChIP-seq profiles across differentiation. Eif2b2 and Brs3 are always Active and Inactive, respectively. Adcy5 and Pkp1 are PRC/S5p in ESC and
days 1/3, but become Active or PRC Only, respectively. Pitx1 maintains the poised PRC/S5p conformation from ESCs until day 30 neurons. Ajuba is Active in ESCs but
acquires H3K27me3 at day 16 while becoming downregulated.
C Proportion of H3K27me3+ promoters (dark red) marked by RNAPII-S5p (purple) throughout differentiation. The vast majority of H3K27me3+ promoters are bound by
RNAPII-S5p in all time points.
D Proportion of H3K27me3+ and S5p+ promoters (purple) marked by S7p (green) throughout differentiation. The number of promoters marked by H3K27me3+S5p+S7p+
increases during differentiation.
E Proportion of H3K27me3 and RNAPII-S5p promoters (purple) that are also transcribed (gold; TPM > 1). The number of actively transcribed promoters increases during
differentiation, in agreement with the increased presence of S7p.
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promoters, while the number of Inactive promoters remains stable
(Fig 5B). The decrease in PRC-positive promoters occurs across all
PRC classes, except for a relative increase in the PRC/Active state
(Fig 5B). By following the changes in promoter state between time
points (Fig EV4B), we show that the increase in the Active promoter
state in days 16 and 30 originates mostly from genes that were PRC
repressed in ESCs to day 3; this transition is accompanied by
increased mRNA expression, as expected from the acquisition of
S7p and loss of H3K27me3 at this group of genes (Fig EV4C). These
genes with newly Active promoter states have specific neuronal
functions (Fig EV4D).
Next, we investigated the promoter state transitions of the genes
associated with the poised PRC/S5p promoter state in ESCs
(Fig 5C). Many of the PRC/S5p genes in ESCs become Active (743/
1913) or PRC/Active (580/1913) in day 30, and have functions in
cell polarity or synaptic activity. Acquisition of S7p is accompanied
by increased mRNA expression, as expected (Fig 5D). Notably, a
group of PRC/S5p genes in ESCs retain the poised conformation in
day 30 neurons (200/1,913 genes; Fig 5C). These genes are impor-
tant developmental transcription factors (TFs) which regulate non-
neuronal cell lineages (e.g., Gata4, Pax7, Nkx3-2). We also find
PRC/S5p genes that resolve to Inactive (129/1,913), with functions
in “germ cell development”, or that become PRC Only (236/1,913),
with functions including “Wnt signalling”.
Other interesting Polycomb-dependent transitions in promoter
activation states are those that result in de novo acquisition of
H3K27me3 in either days 1/3 or days 16/30 (Fig EV5A and B). Most
genes that gain H3K27me3 in days 1 or 3 tend to be Active in ESCs,
and go back to their Active promoter state in day 30, with the acqui-
sition of H3K27me3 in days 1/3 being accompanied by decreased
gene expression (Fig EV5A). The genes that acquire PRC at days 16
or 30 are downregulated at this stage of differentiation, and tend to
be Active in ESCs (Fig EV5B).
Taken together, our results show a role for Polycomb, most often
accompanied by poised RNAPII-S5p complexes, in the silencing of
non-neuronal TFs in neurons and in fine-tuning gene expression
states during differentiation.
H3K27me3 chromatin is co-occupied with RNAPII-S5p complexes
in mature neurons
To test the simultaneous occupancy of RNAPII-S5p and H3K27me3
at Polycomb-repressed genes in terminally differentiated neurons,
we performed sequential ChIP (or re-ChIP; Fig 5E). We
immunoprecipitated chromatin from day 30 neurons with the anti-
body used to map RNAPII-S5p, before re-immunoprecipitation with
different antibodies. We show that the promoter of the Active gene
Actb is co-bound by RNAPII-S5p and RNAPII-S7p, but not by
H3K27me3, as expected (Fig 5F). Notably, the promoters of non-
neuronal transcription factors Pitx1 and Gata4, which are classified
as PRC/S5p in all time points, are co-occupied in neurons by
H3K27me3 and RNAPII-S5p, but not RNAPII-S7p. These results
show that RNAPII-S5p and H3K27me3 simultaneously occupy Poly-
comb-repressed promoters in mature dopaminergic neurons. We
also tested the co-association of H3K27me3 with RNAPII-S5p at
Skap2 and Ajuba, which are PRC/Active genes that acquire
H3K27me3 de novo in day 30, and found that H3K27me3 and
RNAPII-S5p also co-localize at these promoters. In agreement with
the PRC/Active classification, RNAPII-S5p co-immunoprecipitates
with RNAPII-S7p, consistent with the presence of the active
(S5p+S7p+) form of RNAPII at some alleles or in different cells
(Brookes et al, 2012; Kar et al, 2017). None of the marks tested
were enriched at the inactive gene (Myf5), confirming the specificity
of the assay. Re-ChIP with an unrelated antibody, against plant
steroid digoxigenin, was used as a negative control to confirm mini-
mal antibody carryover from the first to the second immunoprecipi-
tation. The sequential ChIP analyses performed here in terminally
differentiated neurons show that RNAPII poising is present at PRC-
repressed genes in post-mitotic neurons.
Poised PRC/S5p promoter states are associated with increased
potential for derepression upon Polycomb knockout or
chemical inhibition
To explore the biological relevance of the poised PRC/S5p promoter
state in ESCs, neuronal progenitors, and neurons, we investigated
the effect of Polycomb knockout at PRC/S5p genes compared to
PRC Only genes. First, we took advantage of published transcrip-
tome resources in ESCs which measured transcriptional derepres-
sion after stable knockout of PRC2 component Eed or conditional
knockout of PRC1 component Ring1B in Ring1A/ background
(Endoh et al, 2008; Cruz-Molina et al, 2017). We find that a larger
proportion of PRC/S5p genes are upregulated in both PRC knockout
cell lines, compared to PRC Only genes (Fig 6A). Only a small frac-
tion of Active and Inactive genes responded to PRC knockout, which
may arise through more indirect regulatory effects associated with
adaptation in the knockout cell lines. Second, we performed similar
analyses using a published microarray dataset from an in vivo PRC2
◀ Figure 5. RNAPII-S5p co-localizes with H3K27me3 in terminally differentiated neurons.A Schematic of gene classification according to the occupancy of H3K27me3, S5p, and S7p at promoter regions (2-kb windows centered on Transcription Start Sites;
TSSs).
B Proportion of genes with each promoter state during terminal neuronal differentiation. Dark red: H3K27me3+ genes.
C PRC/S5p promoters in ESCs and their promoter state in day 30 neurons. Examples of enriched GO terms (determined using as background all PRC/S5p genes in ESCs)
and genes in each category.
D Expression level of PRC/S5p promoters in ESCs and day 30 neurons. Acquisition of S7p correlates with increased expression level. Genes with PRC/S5p, PRC Only, or
Inactive state remain repressed in day 30 neurons.
E Sequential ChIP (re-ChIP) was performed using day 30 neurons to test RNAPII and H3K27me3 co-occupancy, as described in the schematic. The first ChIP with anti-
RNAPII-S5p antibody was followed by a second ChIP using antibodies against RNAPII-S5p (positive control), H3K27me3, RNAPII-S7p, or Digoxigenin (carryover negative
control “Ctrl”).
F Sequential ChIP shows RNAPII-S5p co-association with H3K27me3 at PRC/S5p (Pitx1 and Gata4) and PRC/Active (Skap2 and Ajuba) promoters but not at Active (Actb)
or Inactive (Myf5) promoters. The mean and SD are from two biological replicates.
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knockout in GABAergic striatal medium spiny neurons which
results in neurodegeneration (von Schimmelmann et al, 2016).
Although the neuronal subtypes are not fully matched between the
promoter state classifications from our neuronal cultures, that simu-
late the ventral tegmental area, and the GABAergic neurons from
the striatum, we find that most genes upregulated upon PRC2 loss
in ex vivo striatal neurons have the PRC/S5p promoter state in our
mature day 30 neurons (52 out of the total 150 upregulated genes;
hypergeometric test for enrichment, P = 3.1 × 1056; of note, 39 of
those are PRC/S5p at all stages; Fig 6B). In contrast, only 17 genes
upregulated in the striatal neurons are classified as PRC Only in the
dopaminergic cultures (P = 6.8 × 107), and a smaller proportion of
Active or Inactive genes become upregulated. These results suggest
that the PRC/S5p state leads to increased likelihood for derepression
upon Polycomb loss in both ESCs and differentiated neurons, which
has implications for our understanding of Polycomb roles in main-
taining cell differentiation states.
Lastly, we tested the response of PRC/S5p and PRC Only genes
to PRC2 enzymatic inhibition at three different stages of differentia-
tion (ESC, day 3, and day 30). We used UNC1999, a chemical drug
that blocks the enzymatic activity of both EZH1 and EZH2 (Konze
et al, 2013), in two concentrations (1 and 3 lM), and measured
relative RNA levels by quantitative PCR. We tested six genes that
maintain the PRC/S5p state throughout differentiation (Tal1, Gata4,
Skor1, Pitx1, HoxA7, and Mesp1), three genes that are PRC/S5p in
ESCs but become PRC Only from day 3 onwards (Pouf3, Pkp1, She)
and three genes that maintain the PRC Only promoter state through-
out differentiation (Fam150b, Fgf20, Chdrl2). We find that five out
of the six PRC/S5p genes that maintain their promoter state are
upregulated in ESCs, day 3 and day 30 upon enzymatic inhibition of
PRC2, with increased derepression at the highest inhibitor concen-
tration (Fig 6C). In contrast, none of the analyzed genes acquiring
or maintaining the PRC Only state show detectable RNA levels or
respond to EZH1/2 inhibition at either UNC1999 concentration
in any of the three time points tested. Quality of PCR primers was
verified by agarose gel electrophoresis using genomic DNA
(Appendix Fig S1).
Taken together, these results suggest that the poised RNAPII-S5p
is associated with increased potential for derepression upon loss of
Polycomb repression in ESCs and in differentiated cells at all stages
of maturation, including terminally differentiated neurons both
in vitro and in vivo.
Major non-neuronal transcription factors maintain PRC/S5p
occupancy upon terminal differentiation
To investigate further the significance of the poised PRC/S5p
promoter state during neuronal cell commitment, we focused on
115 genes that maintain the PRC/S5p state during all the sampled
stages of neuronal differentiation (Fig 7A). For comparison, we
chose two other groups of genes which are also PRC/S5p in ESCs
but remain silent in neurons through other promoter states; one
group becomes PRC Only (losing S5p; 127 genes), and the other
becomes Inactive (losing both H3K27me3 and S5p; 92 genes;
Figs 7A and EV6A). Average profiles of H3K27me3 and RNAPII-S5p
occupancy show that these three groups of genes are clearly marked
by both H3K27me3 and RNAPII-S5p in ESCs (Fig 7B; Brookes et al,
2012). The genes that maintain the PRC/S5p promoter state
throughout neuronal differentiation have similar S5p occupancy at
their promoters and throughout the coding region in ESCs, but show
higher average levels of H3K27me3 occupancy in comparison with
genes that resolve to PRC Only or Inactive (Fig 7B). We noticed that
the PRC/S5p genes that maintain their state during neuronal dif-
ferentiation are associated with wider regions of H3K27me3 occu-
pancy compared to genes that lose RNAPII-S5p or to all other
neuronal H3K27me3+ promoters in both ESCs and day 30 neurons
(Fig 7B–D).
To explore the biological relevance of the three groups of genes,
we performed GO enrichment analyses (Fig EV6B). Interestingly,
the group of 115 PRC/S5p genes that maintain their state is enriched
in TFs important for non-neuronal lineages such as Gata4, Mesp1,
Tbx2 (GO term: “heart morphogenesis”), Barx1, Gata6, Hoxb5
(“epithelial cell differentiation”), and Osr2, Pax1, Tcfap2a (“bone
morphogenesis”), suggesting a role for the poised PRC/S5p state in
terminally differentiated neurons in maintaining cell identity and
plasticity by repressing non-neuronal genes.
Key non-neuronal transcription factors that maintain the PRC/
S5p state in neurons have high CpG content
Polycomb occupancy in ESCs is highly correlated to CpG content
(Ku et al, 2008; Deaton & Bird, 2011) and unmethylated CpGs
(Sen et al, 2016). To test whether the retention of the PRC/S5p
state throughout neuronal differentiation is related to high CpG
content, we measured the proportion of the promoter regions
covered by CpG islands, the GC content of TSSs, and the extent of
CpG island coverage of gene bodies. We observe that the promoter
of PRC/S5p genes that maintain the poised state in neurons is
more extensively covered by CpG islands than the genes that
become PRC Only or Inactive (Fig 7E). Their promoter GC content
is also higher (Fig EV6C), and the CpG islands cover longer
portions of gene body (Fig EV6D) than at genes that become Inac-
tive. These results suggest that Polycomb repression in co-associa-
tion with poised RNAPII-S5p correlates with specific sequence
features of gene promoters and gene bodies, namely with high
CpG content.
▸Figure 6. Poised PRC/S5p promoter states have increased potential for reactivation upon loss of Polycomb repression.A Effect of PRC deletion in ESCs (PRC2 component EED and PRC1 components RING1B and RING1A). Barplots represent the percentage of genes which are upregulated
more than twofold according to their promoter state in ESCs.
B Effect of PRC2 deletion in striatal GABAergic medium spiny neurons in 6-month-old mice. Barplot represents the percentage of genes which are upregulated more
than twofold according to their promoter state in day 30 neuron.
C RNA levels of PRC/S5p genes were measured by qRT–PCR upon treatment with EZH1/2 inhibitor UNC1999 at 1 and 3 lM, for 24 h prior to RNA extraction. Relative
levels are normalized to Actb internal control. Three or two biological replicates were performed in ESC and day 3 or in day 30 neurons, respectively. Black lines
connect mean values.
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Key non-neuronal transcription factors that maintain the PRC/
S5p state in neurons are located in DNA methylation valleys
Previous reports have identified DMVs (wide depletions of DNA
methylation, longer than 5 kb) in different cell lineages, which coin-
cide with CpG-rich regions often located at loci encoding for devel-
opmental transcription factors (Xie et al, 2013). To explore the
association of genes that maintain the poised PRC/S5p conformation
throughout differentiation with DMVs, we mined a published
dataset for DNA methylation from mouse frontal cortex (Lister et al,
2013), and classified DMVs (Xie et al, 2013). Visual inspection of
single-gene profiles shows that the regions occupied by H3K27me3
and RNAPII-S5p in neurons often coincide with large stretches of
hypomethylated DNA, as shown for Pitx1 (Fig 7F). Expanding these
observations genome-wide, we find that all genes with PRC/S5p
promoters that maintain their poised state throughout neuronal dif-
ferentiation are hypomethylated in mouse cortex, with the majority
(65%; 70/115) overlapping with DMVs (Fig 7G). In contrast, only
13% (16/127) of genes that become PRC Only or 2% (2/92) of genes
that become Inactive reside in DMVs. Therefore, the maintenance of
the PRC/S5p state is a property of important developmental tran-
scription factors that are also rich in CpG and lack DNA methylation
in terminally differentiated tissues.
Maintenance of PRC/S5p state occurs at the promoters of
developmental transcription factors that are candidate drivers of
trans-differentiation
The observation that key developmental TFs are repressed in post-
mitotic neurons through Polycomb repression in the presence of
poised RNAPII-S5p led us to hypothesize that this conformation
contribute to a state that makes neurons permissive to losing their
identity and potentially to trans-differentiation to other cell types.
To explore this hypothesis, we took advantage of Mogrify, a predic-
tive system of the TFs necessary to induce cell-type reprogramming,
which combines gene expression data with regulatory network
information (Rackham et al, 2016; Fig 8A). We overlapped the TFs
that Mogrify predicts to be important for trans-differentiation to
various cell fates with the promoter states that we have identified in
day 30 neurons. We find that the Mogrify lists of candidate genes
for trans-differentiation toward non-neuronal lineages, such as
cardiomyocytes, skin fibroblasts, and skeletal muscle, are signifi-
cantly enriched in genes marked by H3K27me3 in day 30 neurons,
and especially in genes with the poised PRC/S5p promoter state
(Fig 8B; for additional examples see Fig EV7A). In contrast, the
Mogrify lists of reprogramming TFs are depleted of genes that have
Inactive promoter states in day 30 neurons. We also investigated the
lists of reprogramming TFs predicted to be important for trans-
differentiation to neuronal lineages, including to hippocampus,
neuron, or brain. These genes are more often Active or PRC/Active
in day 30 neurons, unsurprisingly due to their expression in the
neuronal lineage, or alternatively associated with poised PRC/S5p
promoter state (Fig 8B).
Mogrify also ranks TFs according to their importance for trans-
differentiation when they are predicted to regulate a larger number
of the genes required to drive changes in phenotype; these genes are
scored as having high influence on trans-differentiation. In contrast,
the genes that are found to be less important for trans-differentiation
(and scored as low influence) tend to be less connected or to regu-
late genes that are less specific to the target cell type (see schematic
◀ Figure 7. PRC/S5p genes that maintain the poised state throughout differentiation exhibit broader distributions of H3K27me3 and RNAPII-S5pwhich coincidewith DMVs.
A PRC/S5p genes are kept silenced through different mechanisms during neuronal differentiation by maintaining PRC/S5p (Always PRC/S5p; purple), resolving to PRC
Only (light blue), or resolving to Inactive (orange). Colors indicate promoter states in each time point.
B Average ChIP-seq enrichment plots of H3K27me3 and S5p in 10-kb genomic windows centered on transcription start site (TSS) and transcription end sites (TES), in
ESCs.
C Average ChIP-seq enrichment plots of H3K27me3 and S5p in 10-kb genomic windows centered on TSS and TES, in day 30 neurons.
D Boxplot of the length of the genomic regions enriched for H3K27me3 that overlap with promoters in ESC or in day 30 neurons. The length of H3K27me3-enriched
regions covering the remaining H3K27me3+ genes is shown for comparison. P-values are calculated with Wilcoxon rank-sum test.
E Percentage of TSS window covered by CpG islands of PRC/S5p that maintain their state is significantly larger compared to the other gene subgroups. P-values are
calculated with Wilcoxon rank-sum test.
F UCSC Browser tracks of genes classified in day 30 neurons as Always PRC/S5p, PRC Only, Inactive, and Active genes. First row shows methylated (gold) or
hypomethylated DNA methylation valleys (DMVs, dark blue; and smaller regions of hypomethylated DNA, light blue) in mouse frontal cortex.
G Proportion of promoters in the three gene groups which overlap with methylated and hypomethylated DNA. Always PRC/S5p genes are preferentially located at
DMVs. All H3K27me3+ and Inactive genes in day 30 neurons are shown for comparison.
▸Figure 8. Genes with the poised PRC/S5p promoter state in terminally differentiated neurons are enriched for TFs with trans-differentiation potential.A Cells can trans-differentiate into other cell types by forced expression of lineage-specific TFs. The Mogrify algorithm identifies candidate TFs that drive cell conversion
as exemplified in the schematic (Rackham et al, 2016).
B Promoter state of TFs in day 30 which are predicted by Mogrify to drive trans-differentiation toward non-neuronal or neuronal cell types. H3K27me3+ promoters are
enriched in the Mogrify lists of trans-differentiation candidates. PRC/S5p and the PRC/Active genes are the mostly enriched promoter classes. Inactive genes are
depleted. Enrichment and depletion were tested with the hypergeometric test.
C Mogrify ranks all TFs by the likelihood to induce conversion from cell types A to B. By averaging these ranks, it is possible to identify those TFs most frequently
required for a conversion into a certain cell type. The ranks are used to estimate the importance of a given TF to drive the conversion.
D TFs important for driving trans-differentiation toward different cell types were grouped according to their promoter state and tested for enrichment in high or low
importance factors (upwards/downwards arrows). Purple and white backgrounds correspond to enrichment tested for promoter states in day 30 or maintained along
all differentiation, respectively. Enrichment in high or low importance was tested with Gene Set Enrichment Analysis, considered significant when false discovery rate
(FDR) was < 25%.
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in Fig 8C). To test whether genes with high influence are enriched
in PRC-repressed promoter states, we used Gene Set Enrichment
Analysis (GSEA; Subramanian et al, 2005). Interestingly, we find
that genes that have Active promoter states in day 30 neurons are
significantly enriched for low-influence TFs (false discovery rate
< 25%), whereas poised PRC/S5p genes are significantly enriched
in high-influence TFs which are candidates for promoting conver-
sions toward non-neuronal cell fates (Fig 8D; see example in
Fig EV7B). These results show that H3K27me3 and RNAPII-S5p
mark silent genes in neurons which are predicted to be important to
promote trans-differentiation to non-neuronal lineages, suggesting a
role of the poised RNAPII-S5p state in allowing cell identity conver-
sions and of Polycomb repression in stabilizing specific differenti-
ated states.
Discussion
Most genes repressed by Polycomb in ESCs are kept in a poised state
through their association with an unusual form of RNAPII character-
ized by the S5p modification (Stock et al, 2007; Brookes et al, 2012;
Tee et al, 2014; Ma et al, 2016). The PRC/S5p promoter state is
thought to play an important role in the regulation of cell plasticity,
conferring pluripotent stem cells with the ability to rapidly activate
specific subgroups of genes in response to developmental stimuli
(Brookes & Pombo, 2009; Voigt et al, 2012; Di Croce & Helin, 2013).
However, how the interplay between Polycomb and poised RNAPII
evolves upon differentiation has remained unexplored. Here, we opti-
mized an in vitro differentiation approach to obtain functional
dopaminergic neurons at different stages of maturation, and
produced a comprehensive collection of datasets that provides an in
depth profile of the transcriptional and promoter state dynamics
during differentiation. We observe that promoter state transitions
during differentiation are instructed by a tight interplay between
RNAPII poising and Polycomb repression. We show for the first time
that poising of genes by RNAPII-S5p occurs at intermediate and
terminal stages of differentiation, that it associates with increased
potential for derepression upon loss of Polycomb repression, and that
it may have roles in trans-differentiation events in vivo or in vitro.
We show de novo acquisition of PRC marks at many promoters
during differentiation, which coincides with downregulation of gene
expression. Notably, we identify a subgroup of genes that maintain
the poised PRC/S5p conformation throughout all stages of differenti-
ation studied, including many transcription factors important for
specification of non-neuronal lineages. We directly demonstrate the
simultaneous co-association of H3K27me3 and RNAPII-S5p at PRC/
S5p and PRC/Active genes in differentiated neurons using sequen-
tial ChIP, both at genes that maintain the PRC/S5p state and that
acquire PRC de novo.
We observe that the genes that maintain the PRC/S5p state
throughout differentiation have a specific chromatin structure char-
acterized by high CpG content, broad distributions of RNAPII-S5p
and H3K27me3, and overlap with large hypomethylated regions or
DMVs. This cohort of genes is enriched for developmental factors
with key roles in non-neuronal lineages, such as heart, bone, or
epithelium. Differentiated cells can be reprogrammed and their iden-
tities altered in a process called trans-differentiation (Ladewig et al,
2013). To explore the implication of maintaining genes that encode
for lineage-commitment TFs in a poised Polycomb-repressed config-
uration throughout differentiation, we considered whether they are
candidate mediators of trans-differentiation. We discovered that the
TFs that maintain the PRC/S5p promoter state during differentiation
are important candidate drivers of trans-differentiation conversions.
Future studies in other terminally differentiated cell types will help
understand whether the poised chromatin state is an inherent state
of repression for these important transcription factors, or alterna-
tively whether distinct sets of poised PRC/S5p genes are specifically
chosen in each specific cell type to restrict the potential to selec-
tively reprogramming into another cell type, either during the
normal physiology of a tissue or in disease.
In conclusion, our study identifies key roles of Polycomb repres-
sion and RNAPII-S5p poising in modulating the dynamic changes in
gene expression that occur during ESC terminal differentiation into
dopaminergic neurons, and provides comprehensive maps of gene
expression and promoter states of repression which are a valuable
resource for regenerative and developmental biology. Studying gene
regulation in terminally differentiated neurons with a dopaminergic
phenotype is of particular interest for understanding the biology
behind Parkinson’s disease and for the generation of cells for
replacement therapy as possible treatment.
Materials and Methods
Cell culture and differentiation
Cells were grown at 37°C in a 5% (v/v) CO2 incubator. Mouse
embryonic stem cells (ESC-46C; ES cell line E14tg2a that expresses
GFP under Sox1 control; Ying et al, 2003), kindly provided by
Domingos Henrique, were grown in GMEM medium (Invitrogen,
Cat# 21710025), supplemented with 10% (v/v) Fetal Calf Serum
(FCS; BioScience LifeSciences, Cat# 7.01 batch number 110006),
2,000 U/ml LIF (Millipore, Cat# ESG1107), 0.1 mM b-mercap-
toethanol (Invitrogen, Cat# 31350-010), 2 mM L-glutamine (Invitro-
gen, Cat# 25030-024), 1 mM sodium pyruvate (Invitrogen, Cat#
11360039), 1% penicillin-streptomycin (Invitrogen, Cat# 15140122),
1% MEM Non-Essential Amino Acids (Invitrogen, Cat# 11140035)
on gelatin-coated (0.1% v/v) Nunc T25 flasks. The medium was
changed every day, and cells were split every other day. Before
sample collection for ChIP-seq and mRNA-seq, ESCs were plated on
gelatin-coated (0.1% v/v) Nunc 10-cm dishes in serum-free ESGRO
Complete Clonal Grade Medium (Millipore, Cat# SF001-B) to which
was added 1,000 U/ml LIF. Cells were grown for 48 h, with a
medium change at 24 h. ESC batches were tested for mycoplasma
infection.
Early neuronal differentiation was optimized based on the
method described in Abranches et al (2009). ESCs were plated with
high density (1.5 × 105 cells/cm2) in serum-free ESGRO Complete
Clonal Grade Medium (Millipore, Cat# SF001-B) to which
1,000 U/ml LIF was added. After 24 h, ESCs were washed 3 times
with PBS without magnesium and calcium, incubated in PBS for
3 min at room temperature, and then dissociated by incubating in
0.05% (v/v) Trypsin (Gibco, Cat# 25300-054) for 2 min at 37°C.
ESCs were plated onto 0.1% (v/v) gelatin-coated 10-cm dishes
(Nunc) at 1.6 × 106 cells/dish in RHB-A (Takara-Clontech, Cat#
Y40001), changing media every day.
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Mouse EpiSCs were established from ESC-46C after growth
(4 weeks) in N2B27 basal medium containing 20 ng/ml of Activin
(R&D, Cat# 338-AC-050) and 12 ng/ml FGF2 (Peprotech, Cat#
100-18B). The composition of the N2B27 basal medium was as
follows: half of DMEM/F12 (Invitrogen, Cat# 21331-020), half of
Neurobasal Medium (Invitrogen, Cat# 21103-049), 0.5× N2 (Invit-
rogen, Cat# 17502-048), 0.5× B27 (Invitrogen, Cat# 12587-010),
0.05 M b-mercaptoethanol (Invitrogen, Cat# 31350-010), and
2 mM L-glutamine (Invitrogen, Cat# 25030-024). EpiSCs were
grown on Nunc plates coated with FCS (BioScience LifeSciences,
Cat# 7.01 batch number 110006). Culture medium was changed
every day and cells were split every other day, by washing 3
times with PBS without magnesium and calcium, incubating in
PBS for 3 min at room temperature, gently scraping them from
the plate pipetting up and down 3 times, before transferring to a
new FCS-coated plate. The mouse EpiSC-Pitx3-GFP line was previ-
ously established in the Li laboratory (Jaeger et al, 2011), from
ESC-Pitx3-GFP (Zhao et al, 2004). Frozen cell batches were tested
for mycoplasma infection.
EpiSCs were differentiated into day 16 and 30 neurons with
midbrain properties using a protocol optimized based on the
method developed in Jaeger et al (2011).
The day before starting the differentiation protocol (day “1”),
growing EpiSCs were plated on Nunc plates coated with 15 lg/ml
human plasma fibronectin (Millipore, Cat# FC010) and cultured in
N2B27 basal medium containing Activin and FGF2, to reach 70–
80% confluency after 24 h. Differentiation was started by rinsing
cells twice with PBS, and culturing in N2B27 basal medium plus
1 lM PD 0325901 (Axon, Cat# 1408) for 2 days. Medium was
refreshed every day. On day 2, cells were washed with PBS,
scraped, replated on Nunc 10-cm dishes coated with 15 lg/ml
human plasma fibronectin (Millipore, Cat# FC010), and cultured in
N2B27 basal medium for 3 days. At this stage, medium was
refreshed every day by removing half of the volume and adding half
of the volume of freshly prepared medium.
After 72 h, the medium was replaced with N2B27 basal medium
plus 100 ng/ml FGF8 (Peprotech, Cat# 100-25-25) and 200 ng/ml
Shh (R&D, Cat# 464-sh-025). Medium was refreshed every day
by removing half of the volume and adding half of the volume of
freshly prepared medium.
After 96 h, cells were washed with PBS, and the medium
replaced with N2B27 basal medium plus 10 ng/ml BDNF (R&D,
Cat# 450-02-10), 10 ng/ml GDNF (R&D, Cat# 450-10-10), and
200 lM L-ascorbic acid (Sigma, Cat# A4544). Medium was refreshed
every day by removing half of the volume and adding half of the
volume of freshly prepared medium until days 16 and 30.
EZH1 and EZH2 enzymatic inhibition on ESCs, day 3, and day 30
differentiated cells was carried out adding 1 or 3 lM of UNC1999
(Konze et al, 2013; Sigma, Cat# SML0778) dissolved in DMSO,
which were added directly to the medium. Cells treated with
UNC1999 and control cells treated with DMSO were incubated for
24 h with drug or DMSO alone before RNA collection.
mRNA expression
Total RNA was prepared from cells using TRIzol (Invitrogen, Cat#
15596-018) extraction following the manufacturer’s instructions.
Total RNA was treated with TURBO DNase I (Ambion, Cat#
AM1907) according to the manufacturer’s instruction. Extracted
RNA (1 lg) was reverse transcribed with 50 ng random primers and
10 U reverse transcriptase (Superscript II kit, Invitrogen, Cat#
11904-018) in a 20-ll reaction. The synthesized cDNA was diluted
1:10, and 2.5 ll used for qRT–PCR. Results were normalized to
Actb. mRNA libraries were made using TruSeq RNA Sample
Table 1. List of primers for qRT–PCR (50–30).
Actb Fw TCTTTGCAGCTCCTTCGTTG
Rev ACGATGGAGGGGAATACAGC
Nanog Fw ATGAAGTGCAAGCGGTGGCAGAAA
Rev CCTGGTGGAGTCACAGAGTAGTTC
Oct4 Fw CTGAGGGCCAGGCAGGAGCACGAG
Rev CTGTAGGGAGGGCTTCGGGCACTT
Fgf5 Fw CTTCTGCCTCCTCACCAGTC
Rev CACTCTCGGCCTGTCTTTTC
Blbp Fw GGGTAAGACCCGAGTTCCTC
Rev ATCACCACTTTGCCACCTTC
Hes5 Fw AAGTACCGTGGCGGTGGAGAT
Rev CGCTGGAAGTGGTAAAGCAGC
Mash1 Fw TGGAGACGCTGCGCTCGGC
Rev CGTTGCTTCAATGGAGGCAAATG
Sox2 Fw CATGTGAGGGCTGGACTGCG
Rev GCTGTCGTTTCGCTGCGG
Skor1 Fw GCTAAGTGCATCAAGTGCGG
Rev CACGAGTTAAAGTTGGCGGC
Gata4 Fw GAGGCTCAGCCGCAGTTGCAG
Rev CGGCTAAAGAAGCCTAGTCCTTGCTT
HoxA7 Fw AAGCCAGTTTCCGCATCTACC
Rev GTAGCGGTTGAAATGGAATTCC
Pitx1 Fw CAGATCAGCGTCGGACGATT
Rev CACCACCACCGCACGAC
Mesp1 Fw CGCAGTCGCTCGGTCC
Rev GGATGCTGTTTCTGCGTACAG
Pou2f3 Fw GATCCTCTTTAGAGCCCCACCTG
Rev TCAGTGGGCTCATCATTCCCTC
Pkp1 Fw TACGAATGCTTCCAGGACCA
Rev ACTTCTGCCGTTTGACGGT
She Fw CCGTAAGAACTCCCGGGTCA
Rev TCCCATTCTTCTCCTGCGTG
Fam150b Fw CGCTGCTGAGGTTGCTAGTT
Rev CTCTGCTCCTCTTGGTCTGC
Fgf20 Fw GAGGCAGCAAGAAGTGCGA
Rev ATTTCAGTCATCCTGTCCGGC
Chrdl2 Fw GAAAAGATATATACCCCCGGCCA
Rev TCAGAGCAGGTACAGCGCAC
Tal1 Fw GCACCTAGTCCTGCTCAACG
Rev GGCCCTTTAAGTCCCTCGC
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Preparation Kits v2 setA (Illumina, Cat# RS-122-2001) and
sequenced paired-end using Illumina Sequencing Technology by an
Illumina HiSeq2000 following the manufacturer’s instructions. The
primers used are reported in Table 1.
Incorporation of BrdU in replicating cells
To measure replication index, cells were grown in their normal
medium in the presence of 50 lM BrdU (Sigma, Cat# 59-14-3) for
24 h. Cells were fixed (10 min) with 4% freshly depolymerized
paraformaldehyde in 125 mM HEPES (pH 7.8). After washing (2×)
in PBS, cells were permeabilized (20 min) with 0.2% Triton X-100
in PBS and blocked (30 min) with blocking solution (0.5% BSA,
0.2% fish skin gelatin in PBS). Cells were incubated in blocking
solution (1 h, humid dark chamber) to which were added 0.5 U/ll
DNase I (Sigma, Cat# D4263), 3 mM MgCl2, and anti-BrdU antibody
(1:150; raised in mouse which detected BrDNA after in vivo incorpo-
ration of BrdU into replicating DNA; Caltag Laboratories, Cat#
MD5110). Cells were washed (3×, 3 min each) with blocking solu-
tion and incubated (40–60 min) with blocking solution containing
the secondary antibody anti-Mouse IgG conjugated with Alexa Fluor
555 (1:1,000; raised in donkey; Invitrogen, Cat# A31570), in a
humid dark chamber. Cells were rinsed (2×) with blocking solution
and (2×) with PBS. Cells were stained (5 min) in 0.1 mg/ml DAPI in
PBS, washed (1×) with PBS, and mounted using Dako Fluorescence
Mounting Medium (Dako Agilent Technologies, Cat# S3023).
Protein immunofluorescence
Cells were fixed (10 min) with 4% freshly depolymerized
paraformaldehyde in 125 mM HEPES, washed twice with PBS, and
permeabilized (3×, 5 min each) with 0.3% Triton X-100 in PBS
(PBST), by gently rocking. Cells were blocked (30 min) with 3%
donkey serum in PBST and then incubated (at 4°C, overnight), with
primary antibody in PBST+3% donkey serum. Primary antibodies
used were as follows: mouse Tuj1 (1:500; Sigma, Cat# T8660);
mouse anti-OCT4 (1:50; BD Biosciences, Cat# 611202); sheep anti-
TH (1:500; Pel-Freez, Rogers-Arkansas, Cat# P60101-0). After wash-
ing (3×, 10 min each) with PBST, cells were incubated (1 h, in a
humid dark chamber) with secondary antibodies Alexa Fluor 555
anti-mouse IgG (1:1,000; raised in donkey; Invitrogen, Cat# A31570)
or Alexa Fluor 555 anti-sheep IgG (1:500; raised in donkey; Invitro-
gen, Cat# A21436) in PBST+3% donkey serum. After three washes
in PBS (10 min each), cells were incubated (5 min) in 0.1 mg/ml
DAPI in PBS, washed with PBS (3×, 10 min each), before mounting
in Dako Fluorescence Mounting Medium (Dako, Cat# S3023).
For double immunostaining of LMX1A and FOXA2, cells were
permeabilized (3×, 5 min each) with 0.3% Triton X-100 in PBS
(PBST), by gently rocking. Cells were blocked (30 min) with 3%
donkey serum in PBST and then incubated (at 4°C, overnight), with
anti-FOXA2 antibodies (1:200; raised in goat; Santa Cruz, Cat# sc-
6554) in PBST+3% donkey serum. After washing (3×, 10 min each)
with PBST, cells were incubated (1 h, in a humid dark chamber)
with secondary antibodies Alexa Fluor 555 anti-goat IgG (1:500;
raised in donkey; Invitrogen, Cat# A21432) in PBST+3% donkey
serum. Cells were washed (3×, 10 min each) with PBST+3% donkey
serum cells, stored (5 h) in 3% donkey serum in PBST, before incu-
bation (at 4°C, overnight), with guinea pig LMX1A (1:500; clone
GP6; custom-made antibody generated in the Li laboratory) in
PBST+3% donkey serum. After washing (3×, 10 min each) with
PBST, cells were incubated (1 h, in a humid dark chamber) with
secondary antibodies anti-guinea pig IgG conjugated with Alexa
Fluor 488 (1:500; raised in goat; Invitrogen, Cat# A11073) in
PBST+3% donkey serum.
After three washes in PBS (10 min each), cells were incubated
(5 min) in 0.1 mg/ml DAPI in PBS, washed with PBS (3×, 10 min
each), before mounting in Dako Fluorescence Mounting Medium
(Dako, Cat# S3023).
For triple immunostaining of dopaminergic, GABAergic, and
glutamatergic markers (Fig EV3G), fixed cells were washed (3x) in
PBST (PBS containing 0.1% Triton X-100) and incubated 2 h in a
blocking solution that contained 5% donkey serum and 3% BSA in
PBST. Primary antibodies used were as follows: sheep anti-TH
(1:500, Pel-Freez, Rogers-Arkansas, Cat# P60101-0), mouse anti-
VGluT2 (vesicular glutamate transporter 2, 1:1,000, Millipore, Cat#
MAB5504), and rabbit anti-GABA (gamma-aminobutyric acid,
1:1,000, Sigma, Cat# A2052). The primary antibodies were diluted
in blocking solution and incubated overnight at 4°C. The next day,
cells were washed (3×) with PBST and bathed (1 h) in secondary
antibodies Alexa Fluor 488 anti-sheep IgG (1:200, raised in donkey,
Molecular Probes, Cat# A-11015), Alexa Fluor 555 anti-rabbit IgG
(1:200, raised in donkey, Molecular Probes, Cat# A-31572), and
Alexa Fluor 647 anti-mouse IgG (1:200, raised in donkey, Molecular
Probes, Cat# A-31571) diluted in blocking solution, and after three
washes in PBS, mounted with Dako Fluorescence Mounting Medium
(Dako, Cat# S3023).
Microscopy
Single immunofluorescence images (Fig 1C and D) were collected
sequentially on a confocal laser-scanning microscope (Leica TCS
SP8 STED; HC PLAPOCS2 20×/0.75 IMM objective), equipped with
a 405 diode and a WLL (Supercontinuum visible) laser, and pinhole
equivalent to 1 Airy disk. For comparison of the different staining
during neuronal differentiation, images were collected on the same
day using the same settings, and without saturation of the intensity
signal.
Double and triple immunofluorescence images (Figs EV1C and
EV3G) were acquired on a confocal laser-scanning microscope
(Leica TCS SP5; HCX PL APO CS 40.0× 1.25 OIL objective) equipped
with a 405 nm diode, and Argon (488 nm), HeNe (543 nm), and
HeNe (633 nm) lasers.
Electrophysiology
Coverslips of mature neuronal cultures were placed onto a recording
chamber and viewed using an Olympus BX51WI microscope with a
40× water immersion lens and DIC (differential interference
contrast) optics. Cells were bathed at room temperature in a solu-
tion containing (in mM): 140 NaCl, 3.5 KCl, 1.25 NaH2PO4, 2 CaCl2,
1 MgCl2, 10 glucose, and 10 HEPES (pH 7.4). For whole-cell electro-
physiological recordings, low resistance recording pipettes (8–
14 MΩ) were pulled from capillary glass (Harvard Apparatus Ltd.)
and coated with ski wax (Toko) to reduce pipette capacitance.
Recording pipettes were filled with a solution containing: 140 mM
K-gluconate, 5 mM NaCl, 2 mM ATP, 0.5 mM GTP, 0.1 mM CaCl2,
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1 mM MgCl2, 1 mM ethylene glycol-bis (b-aminoethyl ether)-N,N,
N’,N’-tetraacetic acid (EGTA), and 10 mM HEPES (pH 7.4). For
recordings of mIPSCs, a high-chloride solution was used: 135 mM
CsCl, 4 mM NaCl, 2 mM ATP, 0.3 mM GTP, 0.5 mM MgCl2, 2 mM
EGTA, and 10 mM HEPES (pH 7.4). Pitx3-GFP positive neurons
were identified and targeted using fluorescence via a GFP selective
filter (X-Cite series 120, EXFO). For analysis of synaptic physiology,
cells were held in voltage-clamp mode at 70 mV and events were
detected over 3 min of recording. The first 30 s of recording was
used for analysis of action potentials (i.e., frequency and CV-ISI).
Cells were excluded from analysis if they exhibited a holding current
> 150 pA, a series resistance > 30 MΩ, or if the holding current
did not remain stable over the course of recording. Antagonists were
dissolved in the extracellular solution and applied to the cultures
via bath perfusion at 30–33°C. The sodium channel blocker tetrodo-
toxin citrate (TTX) was used at 1 lM (Tocris Bioscience, Cat#
1069). In order to block glutamatergic synaptic activity, 2,3-dioxo-6-
nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX;
Sigma, Cat# N171), an AMPA receptor antagonist, was used at
5 lM, while Picrotoxin (100 lM, Sigma, Cat# P1675), a GABAA
receptor antagonist, was used to identify GABAergic synaptic
events. Data were acquired using an Axon Multiclamp 700B ampli-
fier and a Digidata 1440a acquisition system, with pClamp 10 soft-
ware (Molecular Devices). Data analysis was carried out using
Clampfit 10.2 software (Axon Instruments), OriginPro 8.1 (Origin-
Lab Corporation), Spike2v5 software (Cambridge Electronic
Design), and MiniAnalysis software v6.0.7 (Synaptosoft). Data are
presented as either percentage of cells or the mean  standard error
of the mean (SEM). Statistical analyses were performed using either
chi-squared test for trend or a one-way ANOVA (Kruskal–Wallis;
GraphPad Prism, GraphPad Software, San Diego, CA). Significance
was noted when P < 0.05.
Chromatin immunoprecipitation (ChIP), ChIP-seq, and re-ChIP
The chromatin from ESCs or differentiated cultures was prepared by
cross-linking in 1% formaldehyde for 10 min as previously
described (Stock et al, 2007; Brookes et al, 2012). Arbitrary “chro-
matin concentration” was obtained by measuring absorbance
(280 nm) of alkaline-lysed chromatin, and using the conversion
50 mg/ml for 1 absorbance unit. For mouse anti-RNAPII-S5p (clone
CTD4H8, BioLegend, Cat# 904001), mouse anti-digoxigenin (Jack-
son Immunoresearch, Cat# 200-002-156), and rat anti-RNAPII-S7p
(4E12; Chapman et al, 2007; kindly provided by Dirk Eick) antibod-
ies, protein-G-magnetic beads (Active Motif, Cat# 53014) were incu-
bated with rabbit anti-mouse (IgG + IgM) bridging antibodies
(Jackson Immunoresearch, Cat# 315-005-048; 10 lg per 50-ll
beads) for 1h at 4°C and washed with sonication buffer. For rabbit
anti-H3K27me3 (Millipore, Cat# 07-449) antibodies, magnetic beads
were just washed with sonication buffer. Fixed (700 lg) chromatin
was immunoprecipitated (4°C, overnight) with the specific antibody
and 50-ll beads (with/without bridging antibody), as previously
described (Stock et al, 2007) and (Brookes et al, 2012). After
immunoprecipitation using IgG antibodies, beads were washed as
described previously (Stock et al, 2007). Immune complexes were
eluted from beads (65°C, 5 min then room temperature, 15 min)
with 50 mM Tris–HCl pH 8.0, 1 mM EDTA, and 1% SDS. Elution
was repeated once and eluates pooled. Reverse cross-linking was
carried out (8 h, 65°C) after addition of NaCl and RNase A. EDTA
was then increased to 5 mM, and samples were incubated (50°C,
2 h) with 200 lg/ml proteinase K (Roche, Cat# 3115836001). DNA
was recovered by phenol-chloroform extraction and ethanol precipi-
tation. The final DNA concentration was determined by Quant-iT
PicoGreen dsDNA Assay Kit fluorimetry (Thermo Fisher Scientific,
Cat# P7589). The quality of immunoprecipitated DNA used for high-
throughput sequencing was confirmed prior to library preparation
by quantitative real-time PCR (qPCR) analyses of Active, PRC/S5p,
and Inactive genes with previously characterized chromatin states
(Brookes et al, 2012); these quality control tests are not shown.
Samples were diluted to the same concentration (0.2 ng/ll). The
same amount of immunoprecipitated and input DNA (0.5 ng) was
analyzed by qPCR using primers with the previously published
sequences (Brookes et al, 2012). Amplifications (40 cycles) were
performed using SensiMix No-ROX Kit (Bioline, Cat# QT650-05)
with DNA Engine Opticon 1/2 Real-Time PCR system (Bio-Rad,
Hemel Hempstead, Hertfordshire, UK).
ChIP-seq libraries were prepared from 10 ng DNA (quantified by
PicoGreen and Qubit) using the Next ChIP-Seq Library Prep Master
Mix Set for Illumina (NEB, Cat# E6240) following the NEB protocol,
with some modifications. The intermediate products from the dif-
ferent steps of the NEB protocol were purified using MinElute PCR
purification kit (Qiagen, Cat# 28004). Adaptors, PCR amplification
primers, and indexing primers were from the Multiplexing Sample
Preparation Oligonucleotide Kit (Illumina, Cat# PE-400-1001).
Samples were PCR amplified prior to size selection on an agarose
gel (250–600 bp including adapters). The size range was selected
due to the broad distribution of RNAPII and H3K27me3 at promot-
ers, where there is evidence that protection of DNA may occur
(Ferrai et al, 2007, 2010). After purification by QIAquick Gel Extrac-
tion kit (Qiagen, Cat# 28704), libraries were quantified by Qubit
(Invitrogen) and by qPCR using KAPA Library Quantification Univer-
sal Kit (KapaBiosystems, Cat# KK4824). Library size was assessed
before high-throughput sequencing by Bioanalyzer (Agilent) using
the High Sensitivity DNA analysis kit (Agilent, Cat# 5067-4626).
Fragment sizes were within the selected size distribution. ChIP-seq
libraries were sequenced single-end using Illumina Sequencing
Technology using an Illumina HiSeq2000, according to the manu-
facturer’s instructions.
Re-ChIP experiments were performed as previously described
(Brookes et al, 2012). The first ChIP was performed as described
above with the exception that after the final wash in TE buffer,
immune complexes were eluted from the beads twice (65°C, 5 min,
and room temperature, 15 min) using elution buffer (50 mM Tris
pH 8.0, 1 mM EDTA, and 1% SDS). “Re-ChIP dilution” buffer
(55 mM HEPES pH 7.9, 154 mM NaCl, 1.0 mM EDTA, 1.1% Triton
X-100, 0.11% Na-deoxycholate) was added to dilute the eluate 10-
fold to reach a final SDS concentration of 0.1%. The second round
of immunoprecipitation was set up following the standard ChIP
protocol. Enrichment relative to the input chromatin material was
obtained using qPCR (see above) using the same amount of DNA in
each PCR. To test carryover from the first immunoprecipitation, an
unrelated antibody anti-digoxigenin (raised in mouse; Jackson
Immunoresearch, Cat# 200-002-156) was used in the second round
of immunoprecipitation. As a positive control, RNAPII-S5p ChIP
was repeated in the second immunoprecipitation. The primers used
for Re-ChIP are reported in Table 2.
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Bioinformatics
Read mapping and visualization
Sequenced single-end (50–51 bp) reads originating from ChIP-seq
libraries were aligned to the Mouse reference genome mm10 (Dec.
2011, GRCm38/mm10) using Bowtie2 v2.0.5 (Langmead & Salzberg,
2012). The reference genome was indexed, and the alignments were
performed with default parameters. Replicated reads (i.e., identical
reads, aligned to the same genomic location), occurring more often
than the 95th percentile of the frequency distribution of each
dataset, were removed. When reads originated from multiple runs
(technical replicates of sequencing), datasets were merged after
mapping and removal of replicated reads.
Sequenced paired-end (2 × 100bp) reads from mRNA-seq
libraries were aligned for visualization using TopHat v2.0.8 (Trap-
nell et al, 2009). The gene references provided to TopHat were the
gtf annotation from UCSC Known Genes (mm10, version 6) and the
associated isoform-gene relationship information from the Known
Isoforms table (UCSC). Tables were downloaded from the UCSC
Table browser (http://genome.ucsc.edu/cgi-bin/hgTables). UCSC
Genome Browser (http://genome.ucsc.edu) was used for Figs 4B
and 6E, and EV2A, and EV3G using default view settings, except:
Windowing function—Mean, Smoothing Window—2 pixels and
inclusion of zero on y-axis. Number of mapped reads for the data-
sets produced for this study is shown in Table 3.
Non-redundant gene list selection
To investigate the most representative isoform for each gene in
each time point, we followed the same strategy as in Brookes et al
(2012), applied to mouse genome assembly mm10. To define
isoforms and link them to gene clusters, we used UCSC Known
Gene table (mm10, version 6) and the associated UCSC Known
Isoforms table. Genes belonging to the mitochondrial genome
(chrM) or “random chromosomes” (chr_random) were discarded.
We also discarded clusters not linked to any RefSeq annotation
(from the associated UCSC kgXref table). After filtering, we
obtained a dataset of 23,177 gene clusters, associated with one or
more RefSeq genes.
Around half of the gene clusters, 11,331, had a single isoform.
When more than one isoform (UCSC Known Gene identifier) was
present in a cluster, we selected one isoform per time point using
the following criteria: (i) We selected the gene isoform with the
highest amount of reads for RNAPII-S5p in a 2-kb window
centered on the TSS (Transcription Start Site; in 15.7–17.1% of
gene clusters the isoform was selected at this step); (ii) if ambigu-
ity was still present, we selected the isoform with the highest
RNAPII-S2p in a 4-kb window centered on the TES (Transcription
End Site; in 13.3–13.9% of gene clusters the isoform was selected
at this step); (iii) if ambiguity was still present, we selected the
canonical isoform annotated in the associated UCSC mm10 known
Canonical table (the gene with the highest number of coding
bases; in 20.5–21.3% of gene clusters, the isoform was selected at
this step); and (iv) if ambiguity was still present, one isoform was
selected randomly (in 0.1–0.2% of gene clusters, the isoform was
selected at this step).
Promoter classification
To define genome-wide enriched regions for RNAPII-S5p, RNAPII-
S7p, and H3K27me3, for each time point, we used Bayesian Change-
point Model (BCP) peak-finder (Xing et al, 2012). BCP performs
well in detecting enriched regions for broad chromatin features such
as (broad) histone marks or RNAPII (Harmanci et al, 2014; Thomas
et al, 2016). BCP was run in Histone Mark (HM) mode using as
control dataset: (i) control (digoxigenin) ChIP-seq from ESCs, for
Table 2. List of Re-ChIP primers (50–30).
Actb Fw GCAGGCCTAGTAACCGAGACA
Rev AGTTTTGGCGATGGGTGCT
Pitx1 Fw CAGATCAGCGTCGGACGATT
Rev CACCACCACCGCACGAC
Gata4 Fw TTCCCAGAAAACCGGCGCGA
Rev CCCTTAGGCCAGTCAGCGCA
Skap2 Fw TCCGGCTGTCCAGGGAGGAT
Rev CACCCTATGCGGACGGTGGG
Ajuba Fw GCCCTGCCTCTGCCTCTGTC
Rev CGAGTGACGGCTCTCCTGGC
Myf5 Fw GGAGATCCGTGCGTTAAGAATCC
Rev CGGTAGCAAGACATTAAAGTTCCGTA
Table 3. List of genome-wide ChIP-seq and mRNA-seq datasets
produced in the present study.
Cell type Read type
Mapped reads
(millions)
ChIP-seq dataset
RNAPII-S5p 46C- ESC 1 × 50 bp 46
RNAPII-S5p 46C- day1 1 × 50 bp 82
RNAPII-S5p 46C- day3 1 × 50 bp 75
RNAPII-S5p 46C- day16 1 × 50 bp 95
RNAPII-S5p 46C- day30 1 × 50 bp 58
RNAPII-S7p 46C- ESC 1 × 50 bp 68
RNAPII-S7p 46C- day1 1 × 50 bp 65
RNAPII-S7p 46C- day3 1 × 50 bp 87
RNAPII-S7p 46C- day16 1 × 50 bp 50
RNAPII-S7p 46C- day30 1 × 50 bp 81
H3K27me3 46C- ESC 1 × 50 bp 40
H3K27me3 46C- day1 1 × 50 bp 42
H3K27me3 46C- day3 1 × 50 bp 62
H3K27me3 46C- day16 1 × 50 bp 48
H3K27me3 46C- day30 1 × 50 bp 32
Control (Dig) 46C- ESC 1 × 51 bp 67
Control (Dig) 46C- day16 1 × 50 bp 21
polyA mRNA-seq dataset
ESC 46C- ESC 2 × 100 bp 48
day1 46C- day1 2 × 100 bp 46
day3 46C- day3 2 × 100 bp 47
day16 46C- day16 2 × 100 bp 40
day30 46C- day30 2 × 100 bp 51
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ESC, day 1, and day 3 datasets or (ii) control (digoxigenin) ChIP-seq
from day 16 neurons, for day 16 and 30 datasets. Gene promoters
were considered positive for RNAPII-S5p, RNAPII-S7p, or
H3K27me3 when: (i) the 2-kb windows centered on the TSS over-
lapped with a region enriched for the mark, and (ii) the amount of
reads in the TSS window was above a threshold. The threshold was
defined as the 5th percentile of the distribution of reads in the TSS
window of positive genes (5% tail cut).
To remove overlapping genes, we excluded genes whose (posi-
tive) TSS window overlapped positive windows for the same mark
of other genes for more than 10% (200 bp). Positive genes that were
inside other positive genes for the same mark were also excluded
(internal gene removed). Excluded genes are marked as NA in
Dataset EV2. Genes classified as NA for at least one of the three
marks used for the classification (RNAPII-S5p, RNAPII-S7p, or
H3K27me3) in one time point were excluded from further analyses.
The genes that passed these filters (19,352) were classified, in each
time point, according to the combination of RNAPII and H3K27me3
as belonging to one of eight different promoter states using the
logics presented in main text (Fig 5A). The complete promoter
classification is shown in Dataset EV2.
mRNA-seq analyses
To calculate expression estimates, mRNA-seq reads were mapped
with STAR (Spliced Transcripts Alignment to a Reference, v2.4.2a;
Dobin et al, 2013) and processed with RSEM (RNA-Seq by Expecta-
tion-Maximization, v1.2.25; Li & Dewey, 2011). The references
provided to STAR and RSEM were the gtf annotation from UCSC
Known Genes (mm10, version 6) and the associated isoform-gene
relationship information from the Known Isoforms table (UCSC).
Both tables were downloaded from the UCSC Table browser (http://
genome.ucsc.edu/cgi-bin/hgTables). Gene-level expression esti-
mates in Transcript Per Million (TPM) were used for all the analyses
and are reported in Dataset EV2.
To select genes that peak in one specific time point (Fig 1E), the
expression levels from genes in the non-redundant list were stan-
dardized across time points using z-scores (calculated as the TPM
value in each time point minus the mean value across the five time
points, divided by the standard deviation). Then, genes whose stan-
dardized expression was higher than 1.75 in one time point were
selected. Genes needed to be expressed (> 1 TPM) in at least one
time point to be included in the analysis.
Statistical tests were performed using R, and the name of the test
is specified in main text.
Gene ontology enrichment
Gene ontology (GO) enrichment analysis was performed using GO-
Elite version 1.2.5 (Gladstone Institutes; http://genmapp.org/go_e
lite). Pruned results (to decrease term redundancy) are reported.
Default parameters were used as filters: z-score threshold more than
1.96, P-value < 0.05, number of genes changed more than 2. Over-
representation analysis was performed with “permute P-value”
option, 2,000 permutations. Permute P-value is reported in figures.
UCSC Known Gene IDs were converted into the correspondent
Ensembl Gene IDs (using the UCSC KnownToEnsembl table, down-
loaded from the UCSC Table browser http://genome.ucsc.edu/cgi-
bin/hgTables) before performing the GO enrichment analyses. The
group of genes used as background for each analysis is specified in
the associated figure legend. The complete list of enriched pruned
GO terms is shown in Dataset EV1.
Comparisons with published datasets
To compare PRC-positive genes in this study with previously
published work, the list of genes whose promoter is classified as
positive for H3K27me3 in ESC-46C was overlapped with available
resources as follows: (i) List of genes positive for H3K27me3 in
Young et al, 2011 defined using the classification provided in
Supplementary Table 2 of the corresponding paper. In particular,
genes classified as “Marked”, “Broad”, “Promoter”, or “TSS” in the
“ES H3K27me3” column were considered. Genes were matched with
our classification using Ensembl Gene ID identifiers and converted
from UCSC IDs as previously described. (ii) List of genes positive for
H3K27me3 in Lienert et al, 2011 or in Brookes et al, 2012 were
obtained from Table S2 in Brookes et al, 2012; that is, the genes
classified as “1” in columns “H3K27me3 (TSS) (Lienert et al, 2011)”
or “H3K27me3 (TSS) (Mikkelsen et al, 2007)”, respectively. Genes
were matched with our classification using Gene Symbols. Percent-
ages were calculated as the number of genes positive in both classi-
fications divided for the number of ESC-46C H3K27me3-positive
genes present in the published lists.
To compare PRC/S5p genes in this study with bivalent genes, the
list of genes whose promoter is classified as positive for H3K27me3
and RNAPII-S5p in ESC-46C was overlapped with list of bivalent
genes (“K4+K27”, “ESC”) in Supplementary Table 3 in Mikkelsen
et al, 2007. Genes were matched with our classification using Gene
Symbols. We find 69% of bivalent genes in Mikkelsen et al, 2007
are positive for H3K27me3 and RNAPII-S5p in our ESC datasets.
Upregulated genes in published Polycomb-knockout datasets
To explore the effect of PRC1/2 knockout in ESCs on the genes
which are marked by H3K27me3 in presence or absence of RNAPII-
S5p, we mined published resources. Expression values of wild-type
and Eed-knockout ESCs (Cruz-Molina et al, 2017) were obtained
from GEO Gene Expression Omnibus repository (GSE89210). Identi-
fiers were then matched via Ensembl Gene IDs. Fold change was
calculated as ratio between the average FPKM value in Eed-
knockout ESCs relative to the average FPKM value in wild-type
ESCs. Genes were classified as upregulated if the Fold change was
> 2 and the expression in Eed-knockout ESC was > 1 FPKM. Genes
classified as PRC/S5p, PRC Only or Inactive that were expressed > 1
FPKM in the published datasets for wild-type ESCs were excluded
from the analysis, as these are unlikely to have matched repressed
promoter states. The percentage of upregulated genes in each
promoter state was calculated relative to the number of genes in that
promoter state found in the published dataset.
Expression values of control cells and tamoxifen-induced condi-
tional Ring1B knockout in Ring1A/ knockout cells measured by
microarray (Endoh et al, 2008) were obtained from GEO
(GSM265042 and GSM265043) and analyzed as in (Brookes et al,
2012). Identifiers were matched via Gene Symbols. The percentage
of genes upregulated in each promoter state was calculated in rela-
tion to the number of genes with the same promoter state that are
present in the published datasets.
To explore the effect of PRC2 knockout in neurons on genes
marked by H3K27me3 in the presence or absence of RNAPII-S5p,
we mined a published list of upregulated genes from ex vivo
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medium spiny neurons from 6 month old control and Ezh1/;
Ezh2fl/fl; Camk2a-cre knockout mice, measured by microarray (from
the Supplementary Table 3 in von Schimmelmann et al, 2016).
Genes in the published list were matched with our day 30 list of
promoter states using Gene Symbols. Microarray probes matching
to more than one Gene Symbol were not considered. In the absence
of the total list of detected genes, the percentage of genes upregu-
lated in each promoter state was calculated relative to the total
number of genes in that group.
Plot generation
Heatmaps in Figs 1E and 3B, and EV4B were produced using the
CRAN package pheatmap (Kolde, 2015) in R.
Bar plots, dot plots, and boxplots were produced using Excel or
R. For mRNA-seq, a pseudo-count of 104 was added to TPM prior
to logarithmic transformation and plotting. In Fig 7D, a pseudo-
count of 1 was added to peak size H3K27me3 prior to logarithmic
transformation and plotting.
To facilitate comparison between days, in Fig 3B, the number of
reads mapping in 2-kb windows around the TSS (transformed in log
scale) for each gene was divided by the threshold of minimal
number of reads in positive genes (5% Threshold, see section on
Promoter Classification). To help visualization, these values were
then scaled to have the same maximum value, and the minimum
and maximum values of the color scale were set to 1 and 99% of
the distribution, respectively.
Average ChIP-seq profiles (Fig 7B and C) were generated as
previously (Brookes et al, 2012), by plotting the average coverage
in non-overlapping windows of 10 bp, across genomic windows
centered on the TSS and the TES using custom scripts.
Peak size, GC content, and CpG coverage calculation
To calculate the breath of H3K27me3 windows covering each gene
(Fig 7D), we calculated the size of the BCP-detected enriched
region that overlaps the 2-kb window centered on the TSS of each
gene. If more than one peak was present, the longest was selected.
To calculate the overlap between TSS window or gene body (TSS
to TES) with CpG islands, we used the CpG island definition from
the mm10 cpgIslandExt table, downloaded from UCSC
Table Browser. For each gene, we used the isoform selected in day
30 neurons. The overlap was computed with IntersectBed, part of
Bedtools v2.17.0 (Quinlan & Hall, 2010). To calculate the propor-
tion of TSS window composed of G or C nucleotides, the sequence
of the 2-kb window centered on the TSS used in day 30 was
extracted using bedtools 2.17.0 getfast and analyzed using a custom
script. Statistical tests were performed using R, and the name of
the test is specified in the text.
DNA hypomethylated region and DNA methylation valley definition
Hypomethylated regions (HMRs) from mouse brain, Frontal Cortex
(Lister et al, 2013); dataset name: MouseFrontCortexMale22Mo),
were downloaded from Methbase (Song et al, 2013); http://smith
labresearch.org/software/methbase), a resource from the Smith
laboratory, accessed through the UCSC Table Browser. HMRs were
downloaded as a bed file, already mapped to mm10. DNA methyla-
tion valleys (DMVs) were defined starting from HMR using custom
scripts for proximity clustering and 5-kb size cut-off, following a
previously described approach (Xie et al, 2013).
Mogrify
To identify candidate TFs required to convert a given cell type into
another regardless of their original identity, we extracted the influ-
ence ranks provided by the Mogrify algorithm (Rackham et al, 2016).
These ranks are calculated for each TF for a conversion between any
of 173 cell types or 134 tissue types based on the TFs estimated ability
to regulate the differential expression of its immediate network
neighborhood. For any given cell type, we take the average rank of
the TF over every possible conversion; for instance, the TF Sox2 is
often ranked highly for cell conversions into human neurons and as
such has an average rank of 34.86 (the maximum possible rank is
303). The full list of genes and extracted average ranks for the transi-
tions investigated here can be found in Dataset EV3.
Each human gene was then matched with the mouse homolog
using homology table from Ensembl, release 84 (downloaded
through BioMart http://www.ensembl.org/biomart/). Matching was
performed on Gene Names. Enrichment or depletion in particular
promoter states from day 30 neurons was tested in R with hyper-
geometric test.
Promoter state enrichment in genes with high or low influence
on trans-differentiation (estimated with their rank) was tested
using Gene Set Enrichment Analysis (Subramanian et al, 2005), in
“GSEAPreranked” mode. GSEA tests whether a ranked list (here,
the TFs involved in trans-differentiation) is enriched in certain
Gene Sets (here, different promoter states in day 30 or all days).
In “GSEAPreranked” mode, GSEA is run against a user-supplied,
ranked list of genes (the list of TFs involved in trans-differentia-
tion, using the influence ranks calculated by Mogrify) and tests
for statistically significant enrichment at either end of the ranking.
Enrichment was considered significant at a false discovery rate
< 25%.
Data availability
ChIP-seq and mRNA-seq data have been submitted to the GEO
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